These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6385900)

  • 1. Insulin and glucagon infusion in the treatment of liver failure.
    Jaspan JB; Landau RL; Schneider J
    Arch Intern Med; 1984 Oct; 144(10):2075-8. PubMed ID: 6385900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients.
    Baker AL; Jaspan JB; Haines NW; Hatfield GE; Krager PS; Schneider JF
    Gastroenterology; 1981 Jun; 80(6):1410-4. PubMed ID: 7014349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ornithine alphaketoglutarate on blood insulin, glucagon and aminoacids in alcoholic cirrhosis.
    Gay G; Villaume C; Beaufrand MJ; Felber JP; Debry G
    Biomedicine; 1979 Jul; 30(3):173-7. PubMed ID: 486688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preoperative glucagon-insulin therapy on the patient with hepatic failure secondary to combined valvular disease].
    Kumagae T; Morishita Y; Yuda T; Shimokawa S; Umebayashi Y; Higashi T; Taira A
    Kyobu Geka; 1984 Aug; 37(9 Suppl):732-5. PubMed ID: 6389951
    [No Abstract]   [Full Text] [Related]  

  • 5. Parenteral application of a special amino acid solution in the treatment of severe hepatic encephalopathy.
    Reiter HJ; Bode JC
    Z Gastroenterol; 1978 Jul; 16(7):457-64. PubMed ID: 685343
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of insulin and glucagon infusion to stimulate liver regeneration in fulminant hepatic failure.
    Harrison PM; Hughes RD; Forbes A; Portmann B; Alexander GJ; Williams R
    J Hepatol; 1990 May; 10(3):332-6. PubMed ID: 2195108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early diagnosis of alcoholic cirrhosis by the aminopyrine breath test.
    Saunders JB; Lewis KO; Paton A
    Gastroenterology; 1980 Jul; 79(1):112-4. PubMed ID: 6769747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of acute alcoholic alcoholism].
    Michel H; Larrey D; Blanc P
    Ann Gastroenterol Hepatol (Paris); 1993; 29(1):29-39. PubMed ID: 7680191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of urea synthesis by diet protein and carbohydrate in normal man and in patients with cirrhosis. Relationship to glucagon and insulin.
    Hamberg O
    Dan Med Bull; 1997 Jun; 44(3):225-41. PubMed ID: 9233544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.
    Marchesini G; Fabbri A; Bianchi G; Brizi M; Zoli M
    Hepatology; 1996 May; 23(5):1084-92. PubMed ID: 8621138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation.
    Di Campli C; Angelini G; Armuzzi A; Nardo B; Zocco MA; Candelli M; Santoliquido A; Cavallari A; Bernardi M; Gasbarrini A
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):727-32. PubMed ID: 12811302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
    Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
    Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia.
    Hoff AO; Vassilopoulou-Sellin R
    Cancer; 1998 Apr; 82(8):1585-92. PubMed ID: 9554538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of hepatic encephalopathy].
    Szalay L; Andréka P; Fehér J
    Orv Hetil; 1995 Apr; 136(17):881-7. PubMed ID: 7746657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.
    Oskarsson PR; Lins PE; Backman L; Adamson UC
    Diabetes Metab; 2000 Apr; 26(2):118-24. PubMed ID: 10804326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of glucagon and insulin in therapy of fulminant hepatic failure.
    Okita K; Matsuda S; Hata K; Morimoto T; Sasaki M; Fukumoto Y; Kodama T; Takemoto T
    Gastroenterol Jpn; 1979 Oct; 14(5):453-7. PubMed ID: 520769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
    Baron A; Gulberg V; Sauter G; Waggershauser T; Reiser M; Gerbes AL
    Hepatogastroenterology; 1998; 45(24):2315-21. PubMed ID: 9951915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of hepatic venous pressure gradient in medically treated alcoholic cirrhosis: comparison to aminopyrine breath test.
    Urbain D; Muls V; Makhoul E; Jeghers O; Thys O; Ham HR
    Am J Gastroenterol; 1993 Jun; 88(6):856-9. PubMed ID: 8503380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic protection by perioperative metabolic support?
    Hassanain M; Schricker T; Metrakos P; Carvalho G; Vrochides D; Lattermann R
    Nutrition; 2008; 24(11-12):1217-9. PubMed ID: 18586464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease.
    Schneider JF; Baker AL; Haines NW; Hatfield G; Boyer JL
    Gastroenterology; 1980 Dec; 79(6):1145-50. PubMed ID: 6777231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.